Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business Update

Tuesday, October 31, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. will report its third quarter 2023 financial results after market close on November 7, 2023. Following the announcement, Rigel's senior management will host a live conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial outcomes and provide a business update. The call will be accessible to investors and media, ensuring transparency regarding the company's performance and strategic direction.
Price reaction · baseline $7.804 (2023-10-30 close) · hit after-hours · 1 other RIGL headline(s) in the window, move may be shared
day 0 close · peak
+3.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel is scheduled to report its third quarter financial results soon.
  • The live conference call indicates active investor engagement.
  • There is transparency as results will be discussed in detail during the webcast.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2023 financial results after market close on Tuesday, November 7, 2023. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay 90 days after the call via the Rigel website.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Investors & Media Contact
Rigel Pharmaceuticals, Inc.
Email: [email protected]

Frequently Asked Questions

When will Rigel Pharmaceuticals announce its Q3 2023 results?

Rigel will report its Q3 2023 financial results on November 7, 2023, after market close.

How can I join the Rigel conference call?

You can join the call by dialing 877-407-3088 domestically or 201-389-0927 internationally.

Where can I find the webcast of the conference call?

The webcast will be available on the Investor Relations section of Rigel's website.

What is Rigel Pharmaceuticals known for?

Rigel Pharmaceuticals focuses on developing novel therapies for hematologic disorders and cancer.

How long will the webcast be available for replay?

The webcast will be archived and available for replay for 90 days after the call.

ShareAdd on Google
Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals financial results Q3 2023 business update conference call
Last updated: Oct 31, 2023

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+9%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →